Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. - ADSs
(NQ:
NBTX
)
20.75
+2.31 (+12.53%)
Streaming Delayed Price
Updated: 11:17 AM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nanobiotix S.A. - ADSs
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
May 08, 2023
Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in...
Via
Benzinga
Nasdaq Surges Over 2%; Fluor Posts Downbeat Earnings
May 05, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Friday. The Dow traded up 1.55% to 33,642.02 while the NASDAQ rose 2.21% to 12,231.41. The S&P...
Via
Benzinga
Nanobiotix Stock Triples In Trading Session: What's Going On With Stock On Friday
May 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 05, 2023
Via
Benzinga
Why Are Nanobiotix Shares Plummeting Today?
April 25, 2023
Via
Benzinga
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 05, 2023
Gainers
Via
Benzinga
Crude Oil Rises Sharply; Johnson Controls Earnings Beat Views
May 05, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 1.23% to 33,534.02 while the NASDAQ rose 1.76% to 12,176.68. The S&P...
Via
Benzinga
Dow Jumps 400 Points; US Economy Adds 253,000 Jobs In April
May 05, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 400 points on Friday. Following the market opening Friday, the Dow traded up 1.26% to 33,544.63 while the NASDAQ rose 1.33% to...
Via
Benzinga
Why Is Clearfield (CLFD) Stock Down 28% Today?
May 05, 2023
Clearfield (CLFD) stock is falling on Friday after the company released its earnings report for the fiscal second quarter of 2023.
Via
InvestorPlace
Why is Trupanion (TRUP) Stock Down 32% Today?
May 05, 2023
Trupanion (TRUP) stock is taking a beating on Friday after the pet medical insurance company released its earnings report for Q1 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 05, 2023
Via
Benzinga
Why Is Galmed Pharmaceuticals (GLMD) Stock Up 37% Today?
May 05, 2023
Galmed Pharmaceuticals (GLMD) stock is gaining on Friday after the company announced an investment agreement with OnKai.
Via
InvestorPlace
Why is Nanobiotix (NBTX) Stock Up 107% Today?
May 05, 2023
Nanobiotix (NBTX) stock is taking off on Friday after the company revealed details about ongoing contract negotiations for NBTXR3.
Via
InvestorPlace
Why Carvana Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
May 05, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 05, 2023
Good morning! We're diving into the biggest pre-market stock movers traders will want to keep an eye on for Friday morning!
Via
InvestorPlace
NANOBIOTIX Entering Final Contract Negotiations Following Agreement to Non-Binding Term Sheet for Development and Commercialization of NBTXR3 With a Major Global Pharmaceutical Company
May 05, 2023
Company agreed to term sheet as of May 3, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 27, 2023
Via
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via
Benzinga
NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results
April 24, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023
April 17, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
Earnings Scheduled For April 24, 2023
April 24, 2023
Companies Reporting Before The Bell • Dynex Cap (NYSE:DX) is estimated to report quarterly earnings at $0.17 per share on revenue of $6.99 million.
Via
Benzinga
Voting Rights and Shares Capital of the Company
April 11, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call
March 27, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023
March 14, 2023
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
February 14, 2023
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
January 11, 2023
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer
December 27, 2022
From
Nanobiotix S.A.
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today